To that effect, canagliflozin, another SGLT2 inhibitor, improved memory dysfunction in rats with scopolamine-induced memory impairment [163], likely through a reduction in the acetylcholinesterase (AchE) activity, increased monoamines and acetylcholine M1 receptor (M1 mAchR). Here, ACHE is linked to memory impairment.